NeuroBiology Foundation Background

The Neurobiology Foundation, Inc. is a non-profit 501c(3) tax-exempt organization dedicated to raising funds and providing biomedical research grants with the specific focus of revealing therapeutic targets to facilitate better management of schizophrenia and bipolar disorders.
Over the last few decades, the development of broadly effective pharmaceutical and other biotechnological therapeutics in two of the most severe and debilitating mental illnesses, bipolar disorder and schizophrenia has lacked progress. The complex neurobiology and cultural stigma associated with these illnesses has likely been largely responsible for this deficit along with a paucity in funding of clinical and scientific research programs. Together, this has resulted in little progress which increasingly trails that seen in our understanding and treatment of other forms of mental illness.

It is our intention to change the current state of progress in neurobiology research associated with bipolar disorder and schizophrenia. Our ability to draw upon the combined experience of our Board of Directors who have built professional careers in academic research, product research and development within the pharmaceutical and medical device industries, nonprofit biotechnology research institutions, granting strategy and in philanthropy within healthcare industry to focus on raising and providing funds specifically for research into bipolar disorder and schizophrenia is a significant advantage that will contribute to our success. Excluding the federal NIMH, the number of currently operating nonprofit research organizations with a specific focus on funding external research in these severe mental illnesses is limited to around two separate groups. However these are large with interests in broad and diverse mental illnesses. They have scientific council members amounting to over 140 and board members totaling around 30. Within this landscape, we believe that the Neurobiology Foundation will be successful in efficiently facilitating the critical and highly specific research advances needed to reveal novel therapeutic targets in bipolar disorder and schizophrenia. It is our mission to utilize an efficient organizational strategy to manage the process of raising funds and selecting our grantees to deliver on our stated mission.

____________________________________________________________________